| SOXS 1.79 4.07% | NVDA 177.19 -4.16% | ONMD 1.02 44.60% | NFLX 96.24 13.77% | JEM 0.096 3.90% | ENSC 0.6232 57.77% | BYND 0.9456 15.32% | PLUG 1.79 -6.28% | SOFI 17.76 -7.02% | NVD 7.53 8.50% | TZA 6.23 5.06% | NU 14.98 -0.53% | DUST 3.54 -3.50% | BITO 9.06 -2.78% | EOSE 5.695 -15.50% | XLF 51.43 -2.04% | BAC 49.83 -4.72% | AAL 13.07 -6.24% | MARA 8.94 5.80% | VEEA 0.5071 17.33% | SPY 685.99 -0.48% | SOXL 62.77 -3.93% | SLV 84.99 5.64% | XWEL 1.49 9.56% | QQQ 607.29 -0.32% | ONDS 10.08 -3.54% | BHAT 0.0495 -11.13% | PSKY 13.51 20.84% | INTC 45.61 0.33% | F 14.095 -2.19% | AAPL 264.18 -3.21% | XLE 55.92 1.58% | TQQQ 49.52 -1.06% | TSLA 402.51 -1.49% | HYG 80.72 -0.16% | TSDD 9.18 2.91% | TSLL 14.7 -3.10% | BATL 5.52 33.01% | RKT 18.19 2.36% | RXT 1.95 -14.47% | TLT 90.82 0.61% | TSLS 5.64 1.62% | WBD 28.17 -2.19% | PATH 10.73 0.14% | CRWV 79.56 -18.51% | IBIT 37.19 -2.80% | LQD 111.68 -0.04% | SOUN 8.6015 -4.21% | PLTR 137.19 0.92% | CPNG 19.08 1.98%

Recent Market Trends Highlight Top Gainers

In recent market trends, several companies have emerged as top gainers, showcasing significant price movements and trading volumes. AMTD Digital Inc. (NYSE:HKD) leads with a 93.49% price increase to $3.27, driven by a trading volume of approximately 286.36 million. This surge is supported by a remarkable 1,085.9% revenue increase for the six months ending April 30, 2025, following the consolidation of The Generation Essentials Group as a subsidiary since October 2024, as highlighted by the company.

Beneficient (NASDAQ:BENF) experienced a 57.18% increase in its stock price to $0.87, with a trading volume of over 113.62 million. The company has regained compliance with Nasdaq's periodic filing and market value requirements, which may have contributed to the heightened investor interest. However, Beneficient still needs to address the $1.00 per share bid price requirement to avoid delisting.

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) saw a 50.69% increase in its stock price to $2.18, with a trading volume of over 31.48 million. The company is set to present preclinical data on its innovative RaniPill® capsule at ObesityWeek® 2025, which may have fueled investor interest in its innovative healthcare solutions.

YD Bio Limited Warrants (YDESW) experienced a 47.06% increase in its stock price to $1.5, despite a smaller trading volume of 22,699. The company's focus on detection and therapeutic technologies has shown promising growth potential, attracting investor attention.

These movements reflect a dynamic market environment, with investors showing keen interest in companies across various sectors. The significant price changes and trading volumes highlight the market's responsiveness to company developments, investor sentiment, and broader economic factors.

Published on: October 31, 2025